Risking it All? Going All in on RBM AdoptionBySherraine Hurd,Stephen NabarroFebruary 1st 2015Cancer Research UK (CRUK) followed such advice when it decided to have its Center for Drug Development (CDD) adopt a risk-based monitoring (RBM) approach across its entire portfolio of clinical trials.